Work

Multicenter phase Ib/II study of everolimus (RAD001) and tivozanib (AV-951) in patients with refractory, metastatic colorectal cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.560

Authors: Brian M. Wolpin, Kimmie Ng, Andrew X. Zhu, Thomas Adam Abrams, Peter C. Enzinger, Nadine McCleary, Jeffrey A. Meyerhardt, Deborah Schrag, Eunice Lee Kwak, Jill N. Allen, Pankaj Bhargava, Jennifer A. Chan, Wolfram Goessling, Lawrence Scott Blaszkowsky, Meaghan Elliott, Maria Shellock, Eileen Regan, Charles S. Fuchs

Institutions: AVEO Oncology (United States), Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591074781

Cites:

Cited by: 10

Related to: 10